发明名称 USE OF RIBOFURANOSE DERIVATIVES AGAINST INFLAMMATORY BOWEL DISEASES
摘要 <p>A method for the prophylaxis or treatment of an inflammatory bowel disease is pro­vided, comprising administering to a patient having or at risk of developing an inflammatory bowel disease a therapeutically or preventatively effective amount of one or more ribofu­ranose derivatives having Formula (I), wherein R is a group selected from a carboxamide, an amidine, and pharmaceutically accept­able acid addition salts thereof, and the configuration at the C2 carbon of the ribofuranose moiety is D or L. The one or more ribofuranose derivatives (I) may be used in combination with further active agents such as antivirals or agents effective against inflammatory bowel disease.</p>
申请公布号 WO2005004881(A1) 申请公布日期 2005.01.20
申请号 WO2004CH00430 申请日期 2004.07.08
申请人 ICN PHARMACEUTICALS SWITZERLAND LTD.;BRANTL, VICTOR 发明人 BRANTL, VICTOR
分类号 A61K31/7056;A61P1/00;(IPC1-7):A61K31/705 主分类号 A61K31/7056
代理机构 代理人
主权项
地址